Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Moderna, Inc. (MRNA) had Revenue of $678.00M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$678.00M
Net Income	$-826.00M
Cost of Goods Sold	$452.00M
Gross Profit	$226.00M
Operating Expenses	$1.53B
Operating Income	$-857.00M
Non-Operating Income/Expense	$58.00M
Pre-Tax Income	$-799.00M
Normalized Pre-Tax Income	$-799.00M
Income after Taxes	$-826.00M
Income from Continuous Operations	$-826.00M
Consolidated Net Income/Loss	$-826.00M
Normalized Income after Taxes	$-826.00M
EBIT	$-857.00M
EBITDA	$-803.00M
Weighted-Average Shares Outstanding (Basic)	389.00M
Weighted-Average Shares Outstanding (Diluted)	389.00M
Earnings per Share (EPS) (Basic)	$-2.10
Earnings per Share (EPS) (Diluted)	$-2.10
Balance Sheet Financials
Current Assets	$6.54B
Property, Plant, and Equipment	$2.13B
Long-Term Assets	$5.79B
Total Assets	$12.34B
Current Liabilities	$1.99B
Long-Term Debt	$610.00M
Long-Term Liabilities	$1.70B
Total Liabilities	$3.69B
Common Equity	$8.65B
Tangible Shareholders Equity	$8.65B
Shareholders Equity	$8.65B
Common Shares Outstanding	394.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.87B
Cash Flow from Investing Activities	$1.95B
Cash Flow from Financial Activities	$593.00M
Beginning Cash	$1.93B
End Cash	$2.60B
Increase/Decrease in Cash	$668.00M
Stock-Based Compensation	$483.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.29
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.07
Gross Margin	33.33%
Operating Margin	-126.40%
EBIT Margin	-126.40%
EBITDA Margin	--
Pre-Tax Profit Margin	-117.85%
Profit Margin	-121.83%
Free Cash Flow	$-2.06B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	2.95
Receiveable Turnover	3.68
Days Sales in Receivables	24.42
Return on Equity	-9.55%
Return on Tangible Equity	-9.55%
Return on Assets	-6.69%
Return on Investments	-8.92%
Book Value Per Share	$21.95
Free Cash Flow per Share	$-5.31
Operating Cash Flow per Share	$-4.81

Data from Zacks Investment Research, Inc.